Literature DB >> 18780901

Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune diseases.

Brenda C M de Winter, Teun van Gelder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18780901     DOI： 10.1093/ndt/gfn497

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  [Drug-drug interactions in antirheumatic treatment].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  [Potential interactions of rheumatologic medications in the elderly].

Authors:  U Lange; U Müller-Ladner
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

3.  Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.

Authors:  Brenda C M de Winter; Caroline Monchaud; Aurélie Prémaud; Christophe Pison; Romain Kessler; Martine Reynaud-Gaubert; Claire Dromer; Marc Stern; Romain Guillemain; Christiane Knoop; Marc Estenne; Pierre Marquet; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2012-01-01       Impact factor: 6.447

4.  Compartmentalized biosynthesis of mycophenolic acid.

Authors:  Wei Zhang; Lei Du; Zepeng Qu; Xingwang Zhang; Fengwei Li; Zhong Li; Feifei Qi; Xiao Wang; Yuanyuan Jiang; Ping Men; Jingran Sun; Shaona Cao; Ce Geng; Fengxia Qi; Xiaobo Wan; Changning Liu; Shengying Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

5.  Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.

Authors:  Azrin N Abd Rahman; Susan E Tett; Halim A Abdul Gafor; Brett C McWhinney; Christine E Staatz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

6.  Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study.

Authors:  B Chaigne; P Gatault; F Darrouzain; C Barbet; D Degenne; M François; P Szymanski; N Rabot; G Golea; E Diot; F Maillot; Y Lebranchu; H Nivet; G Paintaud; J-M Halimi; L Guillevin; M Büchler
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

7.  Immunosuppressant mycophenolic acid biosynthesis employs a new globin-like enzyme for prenyl side chain cleavage.

Authors:  Xiwei Chen; Lu Wang; Jinmei Zhang; Tao Jiang; Changhua Hu; Dehai Li; Yi Zou
Journal:  Acta Pharm Sin B       Date:  2019-06-28       Impact factor: 11.413
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.